Education & Training
- Gynecologic Oncology Fellowship Program
- Pediatric Hematology/Oncology Fellowship Program
- Therapeutic Radiology Residency Training Program
- Yale Medical Oncology-Hematology Program
Targeting a Deadly Type of Uterine Cancer -
Endometrial cancer, which originates in the lining of the uterus and is the most common type of gynecological cancer, often has a good prognosis. Patients with the more frequently diagnosed type I are often cured. Type II, however, is responsible for most of the recurrences and deaths that occur in endometrial cancer. Uterine Serous Carcinoma (USC), the most aggressive kind of type II endometrial cancer, accounts for just 10 percent of endometrial tumors and is particularly deadly: in its earliest stages the survival rate can be as low as 50 percent, and for those with more advanced disease, there is no cure.